WHO calls for comments on the revised Target Product Profile for COVID-19 vaccines
20 January 2022
| Meeting report
Overview
WHO calls for comments on the revised Target Product Profile for COVID-19 vaccines:
With almost two years into the COVID-19 pandemic and with vaccines currently licensed or with an emergency use approval and more in the pipeline, WHO has reviewed the Target Product Profile for COVID-19 vaccines. The attached document is now opened for public consultation.
Kindly send your comments or inputs to [email protected] by Friday 4 February 18:00 CET.
WHO Team
R&D Blue Print (RDB),
WHO Headquarters (HQ)
Number of pages
6